Dysregulation of Synaptic Plasticity Markers in Schizophrenia

Overview

Journal Indian J Clin Biochem

Specialty Biochemistry

Date 2023 Jan 23

PMID 36684500

Authors

Neha Keshri

Hanumanthappa Nandeesha

Affiliations

Soon will be listed here.

Abstract

Schizophrenia is a mental disorder characterized by cognitive impairment resulting in compromised quality of life. Since the regulation of synaptic plasticity has functional implications in various aspects of cognition such as learning, memory, and neural circuit maturation, the dysregulation of synaptic plasticity is considered as a pathobiological feature of schizophrenia. The findings from our recently concluded studies indicate that there is an alteration in levels of synaptic plasticity markers such as neural cell adhesion molecule-1 (NCAM-1), Neurotropin-3 (NT-3) and Matrix-mettaloproteinase-9 (MMP-9) in schizophrenia patients. The objective of the present article is to review the role of markers of synaptic plasticity in schizophrenia. PubMed database (http;//www.ncbi.nlm.nih.gov/pubmed) was used to perform an extensive literature search using the keywords schizophrenia and synaptic plasticity. We conclude that markers of synaptic plasticity are altered in schizophrenia and may lead to complications of schizophrenia including cognitive dysfunction.

Citing Articles

The role of netrin G1-netrin-G-ligand-1 in schizophrenia.

Ibiayo A, Yang L, Liu I Tzu Chi Med J. 2025; 37(1):1-9.

PMID: 39850395 PMC: 11753516. DOI: 10.4103/tcmj.tcmj_83_24.

Genetic analysis of psychosis Biotypes: shared Ancestry-adjusted polygenic risk and unique genomic associations.

Xia C, Alliey-Rodriguez N, Tamminga C, Keshavan M, Pearlson G, Keedy S Mol Psychiatry. 2024; .

PMID: 39709506 DOI: 10.1038/s41380-024-02876-z.

Genetic Analysis of Psychosis Biotypes: Shared Ancestry-Adjusted Polygenic Risk and Unique Genomic Associations.

Xia C, Alliey-Rodriguez N, Tamminga C, Keshavan M, Pearlson G, Keedy S medRxiv. 2024; .

PMID: 39677452 PMC: 11643284. DOI: 10.1101/2024.12.05.24318404.

New clues for the role of cerebellum in schizophrenia and the associated cognitive impairment.

Faris P, Pischedda D, Palesi F, DAngelo E Front Cell Neurosci. 2024; 18:1386583.

PMID: 38799988 PMC: 11116653. DOI: 10.3389/fncel.2024.1386583.

Behavioral and transcriptional effects of repeated electroconvulsive seizures in the neonatal MK-801-treated rat model of schizophrenia.

Lee J, Huh S, Park K, Kang N, Yu H, Park H Psychopharmacology (Berl). 2023; 241(4):817-832.

PMID: 38081977 DOI: 10.1007/s00213-023-06511-7.

References

Rivera S, Khrestchatisky M, Kaczmarek L, Rosenberg G, Jaworski D . Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?. J Neurosci. 2010; 30(46):15337-57. PMC: 3072038. DOI: 10.1523/JNEUROSCI.3467-10.2010. View

Huntley G . Synaptic circuit remodelling by matrix metalloproteinases in health and disease. Nat Rev Neurosci. 2012; 13(11):743-57. PMC: 4900464. DOI: 10.1038/nrn3320. View

Kirov G, Grozeva D, Norton N, Ivanov D, Mantripragada K, Holmans P . Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum Mol Genet. 2009; 18(8):1497-503. PMC: 2664144. DOI: 10.1093/hmg/ddp043. View

Dwir D, Giangreco B, Xin L, Tenenbaum L, Cabungcal J, Steullet P . MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients. Mol Psychiatry. 2019; 25(11):2889-2904. PMC: 7577857. DOI: 10.1038/s41380-019-0393-5. View

Stork O, Welzl H, Wolfer D, Schuster T, Mantei N, Stork S . Recovery of emotional behaviour in neural cell adhesion molecule (NCAM) null mutant mice through transgenic expression of NCAM180. Eur J Neurosci. 2000; 12(9):3291-306. DOI: 10.1046/j.1460-9568.2000.00197.x. View

Chenniappan R, Nandeesha H, Kattimani S, Dalavaikodihalli Nanjaiah N . Interleukin-17 and Interleukin-10 Association with Disease Progression in Schizophrenia. Ann Neurosci. 2020; 27(1):24-28. PMC: 7499827. DOI: 10.1177/0972753120929565. View

Kirov G, Gumus D, Chen W, Norton N, Georgieva L, Sari M . Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet. 2007; 17(3):458-65. DOI: 10.1093/hmg/ddm323. View

Sullivan P, Keefe R, Lange L, Lange E, Stroup T, Lieberman J . NCAM1 and neurocognition in schizophrenia. Biol Psychiatry. 2006; 61(7):902-10. DOI: 10.1016/j.biopsych.2006.07.036. View

Maisonpierre P, Belluscio L, Squinto S, Ip N, Furth M, Lindsay R . Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science. 1990; 247(4949 Pt 1):1446-51. DOI: 10.1126/science.247.4949.1446. View

10.

Rajagopalan S, Meng X, Ramasamy S, Harrison D, Galis Z . Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest. 1996; 98(11):2572-9. PMC: 507715. DOI: 10.1172/JCI119076. View

11.

Loffek S, Schilling O, Franzke C . Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance. Eur Respir J. 2010; 38(1):191-208. DOI: 10.1183/09031936.00146510. View

12.

Di Filippo M, Chiasserini D, Gardoni F, Viviani B, Tozzi A, Giampa C . Effects of central and peripheral inflammation on hippocampal synaptic plasticity. Neurobiol Dis. 2013; 52:229-36. DOI: 10.1016/j.nbd.2012.12.009. View

13.

Devanarayanan S, Nandeesha H, Kattimani S, Sarkar S . Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study. Clin Chem Lab Med. 2015; 54(3):447-52. DOI: 10.1515/cclm-2015-0212. View

14.

Sofroniew M, Howe C, Mobley W . Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci. 2001; 24:1217-81. DOI: 10.1146/annurev.neuro.24.1.1217. View

15.

Etherton M, Blaiss C, Powell C, Sudhof T . Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc Natl Acad Sci U S A. 2009; 106(42):17998-8003. PMC: 2764944. DOI: 10.1073/pnas.0910297106. View

16.

Yong V . Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci. 2005; 6(12):931-44. DOI: 10.1038/nrn1807. View

17.

Zakharyan R, Atshemyan S, Gevorgyan A, Boyajyan A . Nerve growth factor and its receptor in schizophrenia. BBA Clin. 2015; 1:24-9. PMC: 4633968. DOI: 10.1016/j.bbacli.2014.05.001. View

18.

Tang X, Zhou C, Gao J, Duan W, Yu M, Xiao W . Serum BDNF and GDNF in Chinese male patients with deficit schizophrenia and their relationships with neurocognitive dysfunction. BMC Psychiatry. 2019; 19(1):254. PMC: 6697959. DOI: 10.1186/s12888-019-2231-3. View

19.

Murakami S, Imbe H, Morikawa Y, Kubo C, Senba E . Chronic stress, as well as acute stress, reduces BDNF mRNA expression in the rat hippocampus but less robustly. Neurosci Res. 2005; 53(2):129-39. DOI: 10.1016/j.neures.2005.06.008. View

20.

Tromp A, Mowry B, Giacomotto J . Neurexins in autism and schizophrenia-a review of patient mutations, mouse models and potential future directions. Mol Psychiatry. 2020; 26(3):747-760. DOI: 10.1038/s41380-020-00944-8. View